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Abstract. The paper refers to a case study on a patient who presented goitre associated with thyroid 
nodules. Patient had a thyroid nodule in the right lobe, fatigue, restlessness, cold extremities - was 
often stressed and crying - and declined the recommended treatment of endocrinologist, using 
complementary remedy DIEE after the results of biocompatibility test with Oberon bio-resonance 
device. As a result of treatment it was recorded stop of disease progression, improved quality of life 
and nodule decreased in dimensions, as evidenced by ultrasound of the thyroid gland. 
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INTRODUCTION    
 
The purpose of this paper is to study the effects of DIEE and DEA - phyto-energy-
therapeutic remedies invented by physicist Ancu Dincă - to a patient with a thyroid nodule 
associated with goitre. Using DEA and DIEE and natural treatment we obtained the desired 
effect removing symptoms and thyroid nodule size decreased to less than half into a period of 
10 months. 
 Thyroid nodule is a thyroid cell proliferation; tumefy appearing in the thyroid 
gland. Ultrasound nodules thyroid detected 30% of women over 50 years and necrotic thyroid 
screening shows the presence of nodular formations generally small in most people. 
In an area with the sufficient contribution of iodine until 10% of women over 50 
have a thyroid nodule clinically measurable. 
Most thyroid nodules are not cancerous, are benign and do not create problems. 
Thyroid nodules can cause three major problems:   
1. Malignancy: only 5% are cancerous and will be surgically excised;  
2. Hyper function: when the node produces too many hormones the thyroid gland is 
overactive or over functional, causing hyperthyroidism;    
3. Local compressive phenomena at large, multiple thyroid nodules, plunged 
character behind the sternum. 
Thyroid nodules are very frequent in the general population, especially women. Their 
incidence increases by age. 
Causes: 
 exposed to environmental radiation;  
 anterior therapeutic irradiation of the neck, head, chest, especially in childhood - it 
increases risk of thyroid nodules; 
 genetically transmission - if a parent has had thyroid nodules, children have higher risk of 
developing thyroid nodules;  
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 goiter and Hashimoto thyroiditis is often associated with risk of thyroid nodules;  
 lack of iodine in foods: areas with iodine deficiency causes endemic goiter.   
Risk factors are female sex and age. 
Classification of thyroid nodules:  
→  1. benign; 
2. malignant - depending on the malignant cell: papillary carcinoma, follicular carcinoma, 
medullar carcinoma, anaplastic poorly differentiated; 
→  1. Solid - grow slowly and are composed of thyroid cell division and multiplication; 
2. Cystic - filled with fluid or blood; 
3. Partially cystic; 
→  1. Solitary, unique - often are colloidal; 
2. Multiples – multi-nodular goitre or nodular toxic goitre.       
Symptoms: 
 Majority are aSMT and indistinguisable; are found at routine examination, during thyroid 
ultrasound, performed for other reasons, the CT scans. If diameter is more than 1 cm 
nodule may be palpable or may notice an increase in volume of the neck; 
 rarely causes - pain or fullness in the neck; 
 swallow difficulty - dysphagia - when pressing the esophagus; 
 breath difficulty - dyspnea - when pressing the trachea; 
 snoring; 
 speak difficulty - hoarse - dysphonia - when pressing the larynx; 
 hyperthyroidism: thyroid hormone excess - choking, nervousness, tachycardia, sweating, 
weight loss; 
 hypothyroidism: the thyroid hormone deficiency - fatigue, depression, constipation, poor 
memory, dry skin, feeling cold; 
 in advanced cases with heart failure appears hyperfunction of thyroid and osteoporosis.    
Laboratory examinations and investigations: 
 hormonal determinations - TSH (thyroid stimulating hormone) hormone tiroidstimulator - 
normal 0.49 to 4.67 micro/ml), T3 (triiodothyronine), T4 (thyroxine - VN 0.71 to 1.85 ng / 
dl), TPOAb (thyroid peroxidase antibody); 
 thyroid ultrasound; 
 thyroid scintigraphy; 
 thyroid biopsy - the only way to check the malignancy; 
 determination of tumor marker: calcitonin and thyroglobulin reveals medullary thyroid 
carcinoma, ACE can mean the dissemination of carcinoma in another organ; 
 fine needle aspiration puncture - drainage of fluid from cystic nodule.   
 
MATERIALS AND METHODS    
 
It was studied an urban patient (woman) diagnosed with thyroid nodule and goitre for 
a period of 10 months. 
Research has focused on studying the same subject human female aged 24 years that 
have been realized assessments of bio-energy-information type using Oberon - non-linear 
analysis - and Ancu Dinca’s bio-phyto-dynamic modulators - DIEE and DEA. 
Complementary treatment method meant the application of DIEE and usage of DEA, 
and phyto-therapy. The bio-phyto-modulators were applied after a treatment schedule. 
Note that this method is a non-invasive treatment, without side effects. 
Patient assessment was made following means: 
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1. Oberon bioresonance device, establishing DIEE and DEA’s biocompatibility and other 
recommended treatments, both at the first consultation, and the following checks; 
2. Thyroid ultrasound – a paraclinical investigation to measure the size of the thyroid gland 
and thyroid nodules. 
During ultrasound exam thyroid nodules are visualized as follows: 
→ if malignant - hypoechogenicity, irregular borders, without back obscurity 
microcalcification with cervical intranodule adenopathy and excessive vascularity; 
→ if benign – hyperechogenicity or izoechogenicity, regular borders or halo, thin-walled 
cysts, continuously hyperechogenic margins as "eggshell", calcification with posterior shadow 
cone. 
 
RESULTS AND DISCUSSIONS    
 
It was studied a student female patient of 24 years old from City of Câmpia Turzii, 
Cluj County, with the diagnosis of thyroid nodules and goitre, which was associated 
symptoms of hypothyroidism and a slight depressive reaction, such as dysmenorrhoea like 
cycle disorder. 
In antecedents, in 2006 nodular goitre is diagnosed by the patient when she presented 
to an endocrinology exam to assess thyroid function. 
It was proposed surgery for cystic thyroid nodule of 23/14 mm from the right lobe. 
He had surgery, but nodule recurred in 5 years, so that she came to our cabinet where 
she was evaluated on Oberon bio-resonance device in order to follow a treatment by applying 
Ancu Dinca’s bio-phyto-modulators, refusing a second surgery procedure.  
It was mention that the patient has genetic load, her mother showing nodular goitre 
with hypothyroidism. Positive diagnosis was established based on history, clinical and 
laboratory data that patient presented us. 
 
 
Fig. 1. Thyroid node of 26/13 mm – ultrasound thyroid interpretation – at the beginning of treatment 
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At the first consultation the patient presented with the following symptoms: fatigue, 
constipation, restlessness, cold extremities, depression, crying, stressed, dysmenorrhoea, 
menstrual disorder, feeling of fullness in the neck, the presence of a thyroid nodule in the 
right lobe. 
To general clinical examination the patient presented: sensibility when touch thyroid, 
presence of a thyroid nodule in the right lobe, increase of thyroid dimensions, cold 
extremities, characteristic of hypothyroidism, bilateral iliac fosse sensitivity. 
Laboratory examinations: in June 24, 2011 - Thyroid ultrasound showed the right 
lobe of 7.6 cm, with a node 26/13 mm with peripheral vascular and 2.4 cm left lobe with 
homogeneous structure, normally vascularised (Fig. 1). 
The patient was evaluated using Oberon bio-resonance device and tested 
biocompatibility of DIEE and DEA, including herbal medications, making a treatment 
schedule for application of devices that it has followed according with recommendations. In 
parallel we recommended the lifestyle change - a diet rich in calcium and vitamin D (dairy 
products, vegetables, fruits, seeds, soy, eggs, fish), and make exercise, avoid stress and 
positive thinking. 
After evaluation with bio-resonance device we have established DIEE and DEA 
biocompatibility values of 36% in case of the first visit, 57% after 5 months, and 79% after 10 
months (Fig. 2). 
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Fig. 2. DIEE and DEA biocompatibility evolution during 10 month of treatment 
 
We mention that, in general, in case of all types of treatment, it is regarded as a 
benefit a biocompatibility over 20 (%), which we actually found in periodic assessments of 
the patient. We followed patients for 10 months. This study aims to analyze bio-phyto-
modulators’ action on the subject - the bio-energy-information harmonization effect that can 
provide them in case of the thyroid gland and thyroid nodule. 
Ultrasound at 5 months reveals size decrease of right lobe to 3.7 cm and left lobe is 
3.4 cm. Hypoechogenetic nodule drops to 9/15 mm (Fig. 3). 
The research was outlined thus: stop the development of thyroid nodule growth, 
decrease nodule’s dimension, bio-energy-information harmony of patient.  
Control results of the patient – after 5 months and 10 months - have indicated a 
reduction in dimension of thyroid nodule that was presented at the first visit (Tab. 1). 
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Fig. 3. Thyroid nodule 9/15 mm – ultrasound thyroid, after using DIEE și DEA 
 
Tab. 1 
Results after the treatment 
 
 
CONCLUSIONS   
 
From our study can be concluded that complementary treatment method using DIEE 
and DEA can be recommended in case of this affection - thyroid nodule associated with goitre 
and menstrual disorders - with great success. It would be necessary to extend this therapeutic 
method in a significant number of cases. 
Non-invasive treatment using complementary DIEE and DEA phyto-energy-
therapeutic remedies have been able to determine the structural vibrate leap including entropy 
reduction, inducing order into system, human body, stopping the increase in dimensions of 
thyroid nodule, (reducing it with more than 50% and providing a better thyroid function), 
creating patient’ bio-energy-information harmonization. 
  DEA and DIEE are able to: 
 to reduce thyroid nodule size; 
 to remove the patient's symptoms of hypothyroidism; 
Control Thyroid’s nodule dimensions / Symptoms 
Paraclinical Exam/ 
Entropy 
Biocompa- 
tibility(%) 
 
First consultation 
26/13mm 
-depression of high intensity;   
constipation, fatigue, dysmenorrhoea 
 
E 5 
 
36 
 
After 5 months 
9/15mm 
- mild depression, bowel adjusted, is no 
longer asthenia, regular cycles 
 
E 4 
 
57 
 
After 10 months 
6,8/6,8 
- no signs of depression, normal bowel 
movements, vigorous, normal cycles 
 
E 2 
 
79 
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 to balance the mind, removing the patient's depressive reaction; 
 to determine self-regulation and stabilization of body functions by activating his reserve 
powers. 
Thyroid dysfunction is a failure of the soul! 
It reflects the mood. - Be happy! 
This is the way to healing! 
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